Safety Profile of Hydroxyethyl Starch
NCT01304433
·
clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Plasma Volume Replacement
Interventions
DRUG:
Venofundin 6% / Tetraspan 6%
Sponsor
B. Braun Melsungen AG